Wayne chats with Paul Kim, Principal of Kendall Square Policy Strategies LLC, and Dr. Susan Mayne, Adjunct Professor at the Yale School of Public Health and former Director of FDA's Center for Food Safety and Applied Nutrition. Together, they dive into the top FDA developments from the first half of 2026 in several areas, as well as the top developments to watch for in the second half of the year. This episode and all bonus episodes do not include the usual Headlines and Resources Links segments. Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at info@fdawatch.net. Music by Dvir Silver from Pixabay.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from FDA Watch
FDA Legal, Regulatory & Compliance Issues, Part 2: Customs Regulation & International Trade
FDA Legal, Regulatory & Compliance Issues, Part 1: FDA & DOJ Enforcement
From Price Strategy to Enforcement Risk
When Pricing Pressure Reaches the FDA File: Practical FDA Realities
Get summaries like this every morning.
Free AI-powered recaps of FDA Watch and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.